Sage Therapeutics has been granted a patent for compounds, including those of Formula (I) and their pharmaceutically acceptable salts, which are useful for preventing and treating various conditions. GlobalData’s report on Sage Therapeutics gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Sage Therapeutics, Anti-inflammatory anesthetics was a key innovation area identified from patents. Sage Therapeutics's grant share as of September 2023 was 34%. Grant share is based on the ratio of number of grants to total number of patents.
A recently granted patent (Publication Number: US11732000B2) discloses a compound and its pharmaceutically acceptable salts for use in pharmaceutical compositions. The patent claims cover a range of compounds and their salts, providing a broad scope for potential applications in the field of medicine.
The patent claims describe a compound selected from a specific group, as well as the pharmaceutically acceptable salts of these compounds. The compounds and salts mentioned in the claims are further specified in subsequent claims, providing additional details on their composition.
The patent also includes claims for pharmaceutical compositions comprising the aforementioned compounds and salts, along with a pharmaceutically acceptable carrier. These compositions can be used for various medical purposes, as they combine the active compound or salt with a carrier that facilitates its administration and delivery.
The granted patent offers a wide range of possibilities for the development of pharmaceutical products. The compounds and their salts described in the claims can potentially be used in the treatment of various diseases and conditions. The inclusion of pharmaceutically acceptable carriers in the compositions ensures their suitability for use in medical settings.
Overall, this patent provides valuable protection for a range of compounds and their salts, allowing for potential advancements in the field of medicine. The broad scope of the claims opens up opportunities for further research and development in the pharmaceutical industry, with the aim of improving patient outcomes and addressing unmet medical needs.
To know more about GlobalData’s detailed insights on Sage Therapeutics, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
